NGNE (Neurogene) Total Assets: $263.14 Mil (As of Mar. 2026)


NGNE Neurogene Inc NGNE
12 GF Score
Price $32.05
! 4 Warning Signs
View Full Analysis

What is Neurogene Total Assets?

Neurogene NGNE +5.26% 12 Total Assets is $263.14 Mil as of Mar. 2026. GuruFocus rates NGNE with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Neurogene's Total Assets for the quarter that ended in Mar. 2026 was $263.14 Mil.

During the past 12 months, Neurogene's average Total Assets Growth Rate was -12.10% per year. During the past 3 years, the average Total Assets Growth Rate was -10.40% per year.

During the past 5 years, Neurogene's highest 3-Year average Total Assets Growth Rate was -9.00%. The lowest was -10.40%. And the median was -9.70%.

Total Assets is connected with ROA %. Neurogene's annualized ROA % for the quarter that ended in Mar. 2026 was -44.85%. Total Assets is also linked to Revenue through Asset Turnover. Neurogene's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Neurogene  (NAS:NGNE) Total Assets Explanation

Total Assets is connected with ROA %.

Neurogene's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-123.736/( (288.604+263.141)/ 2 )
=-123.736/275.8725
=-44.85 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Neurogene's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (288.604+263.141)/ 2 )
=0/275.8725
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Neurogene Total Assets Related Terms

Neurogene Total Assets Historical Data

* Premium members only.

The historical data trend for Neurogene's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurogene Total Assets Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
101.49 109.27 222.57 335.73 288.60

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 315.30 297.32 287.83 288.60 263.14
NGNE
12GF Score
Neurogene Inc NGNE
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neurogene Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Neurogene's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=264.887+23.717
=288.60

Neurogene's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=237.783+25.358
=263.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $263.14 Mil mean?
Neurogene (NGNE) has a Total Assets of $263.14 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Neurogene and its competitors.
Is Neurogene's Total Assets too high?
Neurogene's current Total Assets is $263.14 Mil. Overall, Neurogene has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Neurogene's Total Assets compare to STRO and OCGN?
Neurogene's Total Assets of $263.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Neurogene and its competitors. Neurogene's current Total Assets is $263.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurogene stock overvalued right now?
Neurogene (NGNE) has a current Total Assets of $263.14 Mil. The current Total Assets is $263.14 Mil. Neurogene's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Neurogene (NGNE), the current Total Assets is $263.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neurogene Business Description

Other Exchanges UU8:Germany
Address 535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
12GF Score

Get the complete analysis for NGNE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.05
Price